We combined metabolic magnetic resonance imaging (MRI) sequences at 7 Tesla (7T) to characterize glioma tissue and discover metabolic MRI profiles that could help delineate the extent of disease spread and determine molecular tumor subtypes preoperatively. Here we show the first preliminary results of three different diffuse glioma subtypes imaged with 1H MR spectroscopy (MRS), 31P 3D chemical shift imaging (CSI), glutamate chemical exchange saturation transfer (GluCEST) and quantitative susceptibility mapping (QSM).
No takes yet. Share an insight, caveat, or question.
Jacobs et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: